Yellow Fever Treatment Market Analysis & Forecast 2032

Yellow fever is an epidemic-prone disease caused by the bite of an infected mosquito that can be prevented by vaccination. Yellow fever is caused by an arbovirus (a virus spread by vectors such as mosquitoes, ticks, or other arthropods) that is spread to humans by infected mosquitoes (Aedes and Haemagogus). These mosquitoes breed in houses, in forests or jungles, or in both habitats. Yellow fever is a high-threat disease with a risk of spreading globally, thereby posing a  threat to global health security. The common symptoms of yellow fever include headache, fever, nausea, and vomiting. In severe cases, yellow fever can also affect some organs such as the heart, kidney, and liver.

The global yellow fever treatment market is estimated to be valued at US$ 470.5 million in 2021 and is expected to exhibit a CAGR of 3.7% during the forecast period (2021-2028).

Figure 1.Global Yellow Fever Treatment Market Share (%) in Terms of Value, by Treatment Type, 2021

To learn more about this report, Request sample copy

The increasing prevalence of yellow fever is expected to drive the market growth during the forecast period

The increasing prevalence of yellow fever is expected to drive the market growth of the global yellow fever treatment over the forecast period. For instance, according to an article published in ‘Journal of Medical Virology’, yellow fever affects 84,000 to 170,000 people in Africa each year, with 29,000–60,000 deaths. 

Figure 2.Global Yellow Fever Treatment Market Share (%), by Application, 2021

To learn more about this report, Request sample copy

The increasing use of technology such as artificial intelligence is expected to drive the market growth during the forecast period

Advanced technologies and the use of artificial intelligence are expected to drive the global yellow fever treatment market growth during the forecast period. For instance, in September 2021, scientists from the ‘Research Centre of Biotechnology’ of the Russian Academy of Sciences developed a technology and synthesized five of the most promising compounds and investigated their activity using artificial intelligence. The molecules they chose were related to the derivatives of pyrazosulphonamide.

The above research was conducted in cooperation with Collaborations Pharmaceuticals, Inc., a private company specialized in innovative therapeutics for multiple rare and infectious diseases (based in the U.S.). The team used a predictive computer model in combination with several machine learning methods. For model training, they relied on in vitro screening data and information available in existing databases to select and identify the ideal molecule features for the desired activity. By using these computational models, they predicted their bioactivity before testing them in vitro using NIAID resources.

Global Yellow Fever Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 disease has spread to over 100 countries since its outbreak in December 2019. On January 30, 2020, the World Health Organization (WHO) declared COVID-19 a public health emergency.

The COVID-19 pandemic has impacted clinical trials in a significant way. Various trials have been paused, and researchers have been facing a lot of challenges in visiting remote areas and performing the necessary laboratory and other study assessments required for carrying out the trials effectively.

Furthermore, key players operating in the global yellow fever treatment market also faced various challenges due to the COVID-19 pandemic. The major challenges include the supply of raw materials required for manufacturing drugs due to transportation disruption. Moreover, distributors are facing irregular product demand from retailers due to an increase in the number of patients suffering from COVID-19.

Global Yellow Fever Treatment Market: Restraint

The major factors that hinder the growth of the global yellow fever treatment market include limited treatment options and severity associated with taking wrong medications due to misdiagnosis or incorrect self-diagnosis.

Key Players

Major players operating in the global yellow fever treatment market include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov.